Yung-Sheng Cheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yung-Sheng Cheng has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Shih-Ming Kuo
Division of Pediatric Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical University, Taipei 114202, Taiwan
2 shared publications - Yao-Jen Liang
Graduate Institute of Applied Science and Engineering, Fu Jen Catholic University, New Taipei City, Taiwan
2 shared publications Cheng-Yu Tsai
Department of Surgery, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan
1 shared publicationChi-Hsiang Chung
School of Public Health, National Defense Medical University, Taipei, Taiwan, ROC
1 shared publicationChieh-Hua Lu
Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan, ROC
1 shared publicationChih-Ping Lin
Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan, ROC
1 shared publication
Latest Publications
- Open Access
- 3 August 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (8) , 1751
Predicting Insulin Resistance in Taiwanese Men Using Machine Learning: An Integrated Analysis of Biochemical Markers and Volatile Organic Compounds
Background: Type 2 diabetes (T2D) and insulin resistance (IR) are major global health challenges. Volatile organic compounds (VOCs) in exhaled breath offer a non-invasive window into metabolic dysregulation. This study aimed to predict HOMA-IR using machine learning (ML) by integrating biochemical markers and VOC profiles in a male cohort. Methods: This cross-sectional study included 1258 male participants from the Taiwan MJ cohort. Four ML algorithms (Elastic Net, MARS, Random Forest, and XGBoost) were trained to predict HOMA-IR. Model performance was evaluated using R2, RMSE, and MAE. SHAP analysis was used to interpret feature contributions. Results: Ensemble tree-based approaches (Random Forest and XGBoost) demonstrated better predictive performance than Elastic Net and MARS. Random Forest achieved the highest predictive performance on the test set (R2 = 0.323). SHAP analysis identified BMI (mean |SHAP| = 1.326) as the strongest predictor, followed by TG (1.005) and HDL-C (0.445). Notably, specific breath VOCs, including methanol and formic acid, ranked among the top 20 predictors, capturing distinct aspects of metabolic dysregulation orthogonal to standard blood tests. Conclusions: Integrating VOC profiles with clinical markers provides acceptable predictive performance for IR in men. While traditional metabolic markers dominate the prediction, specific VOCs capture distinct metabolic information, highlighting the potential of breath analysis as a complementary early screening tool.
- 3 August 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (8) , 1751
Open AccessPredicting Insulin Resistance in Taiwanese Men Using Machine Learning: An Integrated Analysis of Biochemical Markers and Volatile Organic Compounds
Background: Type 2 diabetes (T2D) and insulin resistance (IR) are major global health challenges. Volatile organic compounds (VOCs) in exhaled breath offer a non-invasive window into metabolic dysregulation. This study aimed to predict HOMA-IR using machine learning (ML) by integrating biochemical markers and VOC profiles in a male cohort. Methods: This cross-sectional study included 1258 male participants from the Taiwan MJ cohort. Four ML algorithms (Elastic Net, MARS, Random Forest, and XGBoost) were trained to predict HOMA-IR. Model performance was evaluated using R2, RMSE, and MAE. SHAP analysis was used to interpret feature contributions. Results: Ensemble tree-based approaches (Random Forest and XGBoost) demonstrated better predictive performance than Elastic Net and MARS. Random Forest achieved the highest predictive performance on the test set (R2 = 0.323). SHAP analysis identified BMI (mean |SHAP| = 1.326) as the strongest predictor, followed by TG (1.005) and HDL-C (0.445). Notably, specific breath VOCs, including methanol and formic acid, ranked among the top 20 predictors, capturing distinct aspects of metabolic dysregulation orthogonal to standard blood tests. Conclusions: Integrating VOC profiles with clinical markers provides acceptable predictive performance for IR in men. While traditional metabolic markers dominate the prediction, specific VOCs capture distinct metabolic information, highlighting the potential of breath analysis as a complementary early screening tool.
- Open Access
- 24 January 2026
- Published by Springer Nature in BMC Pediatrics
- Vol. 26 (1)
Ileal duplication cyst presenting with recurrent abdominal pain and postoperative Salmonella bacteremia: a case report
Duplication cysts are benign congenital anomalies of the gastrointestinal tract. Most manifest with symptoms within the first two years of life, and the ma
- 24 January 2026
- Published by Springer Nature in BMC Pediatrics
- Vol. 26 (1)
Open AccessIleal duplication cyst presenting with recurrent abdominal pain and postoperative Salmonella bacteremia: a case report
Duplication cysts are benign congenital anomalies of the gastrointestinal tract. Most manifest with symptoms within the first two years of life, and the ma
- Open Access
- 1 November 2025
- Published by SAGE Publications in Therapeutic Advances in Endocrinology and Metabolism
- Vol. 16
Glucagon-like peptide-1 receptor agonists linked to a reduced risk of developing asthma among patients with type 2 diabetes
Background: Studies have suggested that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may modulate asthma-related immune pathways, but evidence directly linking the use of GLP-1 RAs to asthma onset remains limited. Objectives: We aimed to evaluate whether the use of GLP-1 RAs in patients with type 2 diabetes mellitus (T2DM) is associated with a reduced risk and severity of asthma development. Design: This retrospective cohort study was designed to evaluate asthma onset and severity in patients with T2DM treated with GLP-1 RAs, using data from the National Health Insurance Database (2011–2015). Methods: Asthma onset and severity were evaluated in 1345 patients with T2DM treated with GLP-1 RAs from a cohort of 1,936,512 individuals, excluding those with pre-existing asthma. Asthma risk was assessed across four severity levels. Results: The study demonstrated a mean follow-up duration of 2.92 ± 1.82 years. Notably, treatment with GLP-1 RAs significantly reduced asthma risk compared with the non-GLP-1 RA group, as indicated by an adjusted hazard ratio (HR) of 0.67 (95% confidence interval (CI), 0.45–0.76), suggesting a consistent class effect. A protective trend was observed across various severity levels of asthma. The HRs for the GLP-1 RA group compared with the non-GLP-1 RA group for cases with no acute exacerbations (No-AE), acute exacerbations (AE), and status asthmaticus (Status) were 0.55 (95% CI, 0.37–0.62), 0.59 (95% CI, 0.39–0.66), and 0.83 (95% CI, 0.56–0.93), respectively. However, in cases requiring endotracheal intubation, the HR was 0.96 (95% CI, 0.65–1.09). Conclusion: Our study highlights a consistent effect of GLP-1 RAs in reducing asthma risk and severity, except in cases requiring endotracheal intubation, suggesting that GLP-1 RAs may contribute to reducing asthma incidence and severity in patients with T2DM.
- 1 November 2025
- Published by SAGE Publications in Therapeutic Advances in Endocrinology and Metabolism
- Vol. 16
Open AccessGlucagon-like peptide-1 receptor agonists linked to a reduced risk of developing asthma among patients with type 2 diabetes
Background: Studies have suggested that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may modulate asthma-related immune pathways, but evidence directly linking the use of GLP-1 RAs to asthma onset remains limited. Objectives: We aimed to evaluate whether the use of GLP-1 RAs in patients with type 2 diabetes mellitus (T2DM) is associated with a reduced risk and severity of asthma development. Design: This retrospective cohort study was designed to evaluate asthma onset and severity in patients with T2DM treated with GLP-1 RAs, using data from the National Health Insurance Database (2011–2015). Methods: Asthma onset and severity were evaluated in 1345 patients with T2DM treated with GLP-1 RAs from a cohort of 1,936,512 individuals, excluding those with pre-existing asthma. Asthma risk was assessed across four severity levels. Results: The study demonstrated a mean follow-up duration of 2.92 ± 1.82 years. Notably, treatment with GLP-1 RAs significantly reduced asthma risk compared with the non-GLP-1 RA group, as indicated by an adjusted hazard ratio (HR) of 0.67 (95% confidence interval (CI), 0.45–0.76), suggesting a consistent class effect. A protective trend was observed across various severity levels of asthma. The HRs for the GLP-1 RA group compared with the non-GLP-1 RA group for cases with no acute exacerbations (No-AE), acute exacerbations (AE), and status asthmaticus (Status) were 0.55 (95% CI, 0.37–0.62), 0.59 (95% CI, 0.39–0.66), and 0.83 (95% CI, 0.56–0.93), respectively. However, in cases requiring endotracheal intubation, the HR was 0.96 (95% CI, 0.65–1.09). Conclusion: Our study highlights a consistent effect of GLP-1 RAs in reducing asthma risk and severity, except in cases requiring endotracheal intubation, suggesting that GLP-1 RAs may contribute to reducing asthma incidence and severity in patients with T2DM.
- Open Access
- 31 August 2023
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 13 (9) , 1350
Comparative Evaluation of Tissue Adhesives and Sutures in the Management of Facial Laceration Wounds in Children
Background: This study evaluated tissue adhesives in comparison to sutures for treating facial lacerations in children. Methods: We retrospectively analyzed data from September 2017 to August 2022 involving pediatric facial lacerations managed with either tissue adhesives or sutures. Results: Among 50 children, 20 received tissue adhesives, and 30 received sutures. Both methods showed comparable outcomes in terms of wound complications such as dehiscence (adjusted odds ratio = 1.56, 95% CI = 0.08–31.25) and infection (adjusted odds ratio = 2.17, 95% CI = 0.08–58.80). The cosmetic outcomes, assessed using the Hollander Wound Evaluation Score, were also consistent between groups (adjusted beta = −0.55, 95% CI = −1.15–0.05). Notably, those treated with tissue adhesives reported greater satisfaction (adjusted beta = 1.13, 95% CI = 0.63 −1.63) and experienced significantly less pain (adjusted beta = −3.03, 95% CI = −4.15–−1.90). Conclusions: Both techniques displayed similar rates of infection, dehiscence, and cosmetic outcomes. However, tissue adhesives were associated with increased patient comfort, especially in terms of reduced pain and greater satisfaction.
- 31 August 2023
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 13 (9) , 1350
Open AccessComparative Evaluation of Tissue Adhesives and Sutures in the Management of Facial Laceration Wounds in Children
Background: This study evaluated tissue adhesives in comparison to sutures for treating facial lacerations in children. Methods: We retrospectively analyzed data from September 2017 to August 2022 involving pediatric facial lacerations managed with either tissue adhesives or sutures. Results: Among 50 children, 20 received tissue adhesives, and 30 received sutures. Both methods showed comparable outcomes in terms of wound complications such as dehiscence (adjusted odds ratio = 1.56, 95% CI = 0.08–31.25) and infection (adjusted odds ratio = 2.17, 95% CI = 0.08–58.80). The cosmetic outcomes, assessed using the Hollander Wound Evaluation Score, were also consistent between groups (adjusted beta = −0.55, 95% CI = −1.15–0.05). Notably, those treated with tissue adhesives reported greater satisfaction (adjusted beta = 1.13, 95% CI = 0.63 −1.63) and experienced significantly less pain (adjusted beta = −3.03, 95% CI = −4.15–−1.90). Conclusions: Both techniques displayed similar rates of infection, dehiscence, and cosmetic outcomes. However, tissue adhesives were associated with increased patient comfort, especially in terms of reduced pain and greater satisfaction.
- Open Access
- 1 January 2017
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 34 (C) , 36-39
Pulmonary metastatic angiosarcoma from scalp with fatal complication
INTRODUCTION: Angiosarcoma is a rare malignant neoplasm with poor prognosis. Angiosarcoma of the scalp is frequently recurs locally, and metastasizes early despite various treatments. The common sites of metastatic are lung, liver, and lymph nodes. Pulmonary metastasis with hemoptysis and pneumothorax is rare but threatening. PRESENTATION OF CASE: A 77-year-old male had recurrent angiosarcoma of the scalp even with post operation radiotherapy. At the same time, recurrent pneumothorax was noted, thus he underwent wedge resection of the right upper lobe of the lung plus pleural biopsy. The final pathologic report of cystic lesions showed metastatic Angiosarcoma. He received intravenous paclitaxel and the lung lesions dramatically diminished subsequently. DISCUSSION: Pulmonary metastasis from soft tissue sarcoma had fatal complications and poor prognosis. Metastases of AS to the lung have a well-described morphology on CT scan, but appear to be hypometabolic on PET scan and are easily misinterpreted as benign cysts. CONCLUSION: Angiosarcoma is a rare but highly vascular invasive endothelial tumor that generally metastasizes to the lung. It could cause repeated hemoptysis pneumothorax and pleural effusion. Preoperative chest CT may be recommended routinely. Aggressive treatment resulted in not only symptoms control but also good prognosis. Highlights:
- 1 January 2017
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 34 (C) , 36-39
Open AccessPulmonary metastatic angiosarcoma from scalp with fatal complication
INTRODUCTION: Angiosarcoma is a rare malignant neoplasm with poor prognosis. Angiosarcoma of the scalp is frequently recurs locally, and metastasizes early despite various treatments. The common sites of metastatic are lung, liver, and lymph nodes. Pulmonary metastasis with hemoptysis and pneumothorax is rare but threatening. PRESENTATION OF CASE: A 77-year-old male had recurrent angiosarcoma of the scalp even with post operation radiotherapy. At the same time, recurrent pneumothorax was noted, thus he underwent wedge resection of the right upper lobe of the lung plus pleural biopsy. The final pathologic report of cystic lesions showed metastatic Angiosarcoma. He received intravenous paclitaxel and the lung lesions dramatically diminished subsequently. DISCUSSION: Pulmonary metastasis from soft tissue sarcoma had fatal complications and poor prognosis. Metastases of AS to the lung have a well-described morphology on CT scan, but appear to be hypometabolic on PET scan and are easily misinterpreted as benign cysts. CONCLUSION: Angiosarcoma is a rare but highly vascular invasive endothelial tumor that generally metastasizes to the lung. It could cause repeated hemoptysis pneumothorax and pleural effusion. Preoperative chest CT may be recommended routinely. Aggressive treatment resulted in not only symptoms control but also good prognosis. Highlights: